« Previous
Next »
Titles
- Assessing user fees under the Prescription Drug User Fee Amendments of 20171
- Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents1
- Brand name prescription drug prices increase four times faster than inflation in 20171
- How does the Trump Administration drug pricing blueprint affect Medicaid?1
- Searching for savings in Medicare drug price negotiations1
- Summary of recent and proposed changes to Medicare prescription drug coverage and reimbursement1
- Trends in retail prices of brand name prescription drugs widely used by older Americans: 2017 year-end update1